Fig. 4From: Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetesEpicardial adipose tissue FDG uptake: Representative FDG PET/CT scan of a patient of dapagliflozin group showing SUV mean and SUV max at left circumflex artery (CX) at baseline (A) and after 4 weeks of treatment (B)Back to article page